When does Thermo Fisher report earnings?
Thermo Fisher Scientific Inc. · end-of-day data as of Nov 13, 2026
- ConsensusBuy · 27
- MAs4 of 4
- Sector▲ +15.9%
- Earnings in83d
- P/E36.9x
- RSI54
- Support-3.3%
- Resistance+0.4%
- Off 52w high-3.8%
- Volume0.8x
- Bollingerupper half
- News1.00
- FCF yield+2.9%
- PT$706.70 +0.9%
- Trendsideways
- 52w range$435–$728
- ATR+2.9%
- Off ATH-3.8%
- P/E vs own+21.2%
- P/E vs sector+14.6%
- Insiders-$24.29M
- MACD-0.81
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
The stock around its reports
Last close $700.22 · +28.9% over 2y · E earnings · D dividend · S split · A analyst rating change
Quarterly results
Q3 FY2026: Revenue +9.1% year over year, free cash flow 17.4% of revenue, operating margin 18.6%.
| Q3 FY2026 | Sep 26, 2026 | $12.14B | 4.64 | $2.11B | 42.8% | 18.6% | 14.2% |
| Q2 FY2026 | Jun 27, 2026 | $11.99B | 4.68 | $1.68B | 41.2% | 17.4% | 14.5% |
| Q1 FY2026 | Mar 28, 2026 | $11.01B | 4.43 | $816M | 40.7% | 16.9% | 15.0% |
| Q4 FY2025 | Dec 31, 2025 | $12.21B | 5.21 | $2.99B | 41.0% | 18.8% | 16.2% |
| Q3 FY2025 | Sep 27, 2025 | $11.12B | 4.27 | $1.83B | 41.2% | 18.7% | 14.5% |
| Q2 FY2025 | Jun 28, 2025 | $10.85B | 4.28 | $1.1B | 40.6% | 17.7% | 14.9% |
| Q1 FY2025 | Mar 29, 2025 | $10.36B | 3.98 | $361M | 41.0% | 17.8% | 14.5% |
| Q4 FY2024 | Dec 31, 2024 | $11.39B | 4.78 | $2.81B | 39.2% | 19.9% | 16.1% |